Apple Inc. vs. Iambic Therapeutics, Inc. Common Stock
Apple Inc. and Iambic Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AAPL | IAM | |
|---|---|---|
| Market Cap | $5.01 trillion | — |
AAPL and IAM split the size & scale factors evenly.
Dividend
| AAPL | IAM | |
|---|---|---|
| Dividend Yield | 0.31% | — |
AAPL and IAM split the dividend factors evenly.
Risk & Sentiment
| AAPL | IAM | |
|---|---|---|
| Short Interest | 0.31% | — |
AAPL and IAM split the risk & sentiment factors evenly.
Dig deeper: AAPL overview, AAPL financials, IAM overview, IAM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.